Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis

Patients with non-small-cell lung cancer (NSCLC) have a low survival rate. Long non-coding RNA (LncRNA) LANCL1 antisense RNA 1 (LANCL1-AS1) was indicated to be downregulated in NSCLC; however, its detailed function in NSCLC is unanswered. Real-time quantitative polymerase chain reaction revealed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Hui, Peng, Jing, Qiao, Xiaoni, Gao, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024345/
https://www.ncbi.nlm.nih.gov/pubmed/36941990
http://dx.doi.org/10.1515/med-2023-0666
_version_ 1784909082697662464
author Pan, Hui
Peng, Jing
Qiao, Xiaoni
Gao, Han
author_facet Pan, Hui
Peng, Jing
Qiao, Xiaoni
Gao, Han
author_sort Pan, Hui
collection PubMed
description Patients with non-small-cell lung cancer (NSCLC) have a low survival rate. Long non-coding RNA (LncRNA) LANCL1 antisense RNA 1 (LANCL1-AS1) was indicated to be downregulated in NSCLC; however, its detailed function in NSCLC is unanswered. Real-time quantitative polymerase chain reaction revealed the downregulation of LANCL1-AS1 in NSCLC cell lines and subcellular fractionation assay showed that LANCL1-AS1 was mainly located in the cytoplasm of NSCLC cells. Cell counting kit-8, Transwell, and tube formation assays displayed that overexpression of LANCL1-AS1 suppressed NSCLC cell proliferation, migration, invasiveness, and angiogenesis in vitro. Animal experiments validated the tumor-suppressive role of LANCL1-AS1 in tumor-bearing mice. Mechanistically, LANCL1-AS1 upregulated glia maturation factor gamma (GMFG) expression by competitively binding to miR-3680-3p. GMFG knockdown reversed LANCL1-AS1 overexpression-mediated inhibitory impact on NSCLC malignant behaviors. Collectively, LANCL1-AS1 upregulation inhibits the progression of NSCLC by modulating the miR-3680-3p/GMFG axis.
format Online
Article
Text
id pubmed-10024345
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-100243452023-03-19 Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis Pan, Hui Peng, Jing Qiao, Xiaoni Gao, Han Open Med (Wars) Research Article Patients with non-small-cell lung cancer (NSCLC) have a low survival rate. Long non-coding RNA (LncRNA) LANCL1 antisense RNA 1 (LANCL1-AS1) was indicated to be downregulated in NSCLC; however, its detailed function in NSCLC is unanswered. Real-time quantitative polymerase chain reaction revealed the downregulation of LANCL1-AS1 in NSCLC cell lines and subcellular fractionation assay showed that LANCL1-AS1 was mainly located in the cytoplasm of NSCLC cells. Cell counting kit-8, Transwell, and tube formation assays displayed that overexpression of LANCL1-AS1 suppressed NSCLC cell proliferation, migration, invasiveness, and angiogenesis in vitro. Animal experiments validated the tumor-suppressive role of LANCL1-AS1 in tumor-bearing mice. Mechanistically, LANCL1-AS1 upregulated glia maturation factor gamma (GMFG) expression by competitively binding to miR-3680-3p. GMFG knockdown reversed LANCL1-AS1 overexpression-mediated inhibitory impact on NSCLC malignant behaviors. Collectively, LANCL1-AS1 upregulation inhibits the progression of NSCLC by modulating the miR-3680-3p/GMFG axis. De Gruyter 2023-03-13 /pmc/articles/PMC10024345/ /pubmed/36941990 http://dx.doi.org/10.1515/med-2023-0666 Text en © 2023 the author(s), published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Research Article
Pan, Hui
Peng, Jing
Qiao, Xiaoni
Gao, Han
Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
title Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
title_full Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
title_fullStr Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
title_full_unstemmed Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
title_short Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
title_sort upregulation of lncrna lancl1-as1 inhibits the progression of non-small-cell lung cancer via the mir-3680-3p/gmfg axis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024345/
https://www.ncbi.nlm.nih.gov/pubmed/36941990
http://dx.doi.org/10.1515/med-2023-0666
work_keys_str_mv AT panhui upregulationoflncrnalancl1as1inhibitstheprogressionofnonsmallcelllungcancerviathemir36803pgmfgaxis
AT pengjing upregulationoflncrnalancl1as1inhibitstheprogressionofnonsmallcelllungcancerviathemir36803pgmfgaxis
AT qiaoxiaoni upregulationoflncrnalancl1as1inhibitstheprogressionofnonsmallcelllungcancerviathemir36803pgmfgaxis
AT gaohan upregulationoflncrnalancl1as1inhibitstheprogressionofnonsmallcelllungcancerviathemir36803pgmfgaxis

Ejemplares similares